Delivery Order SPE2DB22D2206-SPE2DB25FJD65
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,935.50 to AmerisourceBergen Drug Corp for the supply of Alvimopan 12 mg capsules in unit dose packs of 30 units. This competitively awarded, firm fixed-price delivery order was issued on July 22, 2025, with an ultimate completion date of July 23, 2025. The contract does not include a set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $11,346.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 unit-dose capsules of Alvimopan 12 mg, with a completion date of July 23, 2025. This non-set-aside competitive award reflects AmerisourceBergen's role as a critical pharmaceutical supplier within the federal medical procurement system. The product is being delivered to the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under...
- The Defense Logistics Agency awarded a $4,937.71 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a for-profit global pharmaceutical distribution company. The order is for the supply of Alvimopan 12 mg capsules and has a completion date of February 14, 2024. This delivery order is issued under an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $8,496.73 firm fixed price delivery order is for the supply of the pharmaceutical product Alvimopan 12 mg capsules, with a period of performance through April 2, 2024. Amerisourcebergen Drug Corp has an existing indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00...
- This is a firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $2,492.62 contract is for the supply of ALVIMOPAN 12 MG CAPSULE UD 30S, a medication. The contract has an ultimate completion date of June 20, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,568,601,268 units of the pharmaceutical product Alvimopan 12 mg capsules. The total ceiling value of the contract is $47,144.31, with a performance period extending to June 23, 2025. The contract is not set aside and was awarded on an open competition basis....
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, to provide ALVIMOPAN 12 MG CAPSULE UD 30S. The contract has a potential value of $4,937.71 and a completion date of January 30, 2024. This delivery order is issued under an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $2,080.46 firm fixed-price delivery order is for the provision of 4,564,898,629 units of the prescription medication Alvimopan 12 mg capsules. The award does not include a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation, to provide 30-count unit dose packages of the drug Alvimopan 12 mg capsules. The $4,807.56 contract has a completion date of March 5, 2024. AmerisourceBergen Drug Corp is the prime contractor and does not have any major subcontractors listed. The contract was not set aside for any specific...
- AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $11,404.40 by the Defense Logistics Agency's Medical Supply Chain on July 21, 2025. The contract is structured as a firm fixed price delivery order with an ultimate completion date of July 22, 2025, and represents a non-competitive award under an existing indefinite delivery contract vehicle. This delivery order is a child contract under...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJD65Delivery Order
The Defense Logistics Agency awarded a $5,167.68 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Alvimopan 12 mg capsule unit dose packets (30-count). This non-set-aside contract will be performed at the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 31, 2025. The delivery order represents a near-immediate fulfillment requirement typical of pharmaceutical supply chain operations supporting federal healthcare systems. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime vehicle enables comprehensive pharmaceutical support across multiple therapeutic domains for military healthcare programs worldwide, including products supplied to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. AmerisourceBergen's competitive award history and established role as a major pharmaceutical distributor position the company as a critical vendor for federal medical procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.2k | 7/30/25 |